skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study

Original Research

(2016) Views  (641) Full article downloads

Authors: Ramona S DeJesus, Rajeev Chaudhry, Dorinda J Leutink, et al

Published Date August 2009 Volume 2009:5 Pages 705 - 711
DOI: http://dx.doi.org/10.2147/VHRM.S5086

Ramona S DeJesus1, Rajeev Chaudhry1, Dorinda J Leutink2, Melanie A Hinton1, Stephen S Cha3, Robert J Stroebel1

1Division of Primary Care Internal Medicine, 2Quality Management Services, 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA

Abstract: There continues to be a need for improved medical management of diabetes patients with hypertension in primary care. While several care models have shown effectiveness in achieving various outcomes among these patients, it remains unclear what care model is most effective in improving blood pressure control in primary care. In this prospective study, 54 patients with type 2 diabetes mellitus and blood pressure of >140/90 identified through the registry, were randomized into three groups. Group A attended a nurse educator-conducted class on diabetes and hypertension, group B attended the same class and was asked to monitor their home blood pressure using provided device, and group C served as control (usual care). Of the 24 subjects who completed the study, only 20% achieved the target blood pressure of <130/80 and there was no statistical difference in mean systolic and diastolic blood pressures among the three groups (p > 0.05). Efforts to intensify management of hypertension among type 2 diabetes patients did not result in better blood pressure control compared to usual care. Studies looking into factors which limit patients’ participation in group classes and determining patients’ preferences in disease management would be helpful in ensuring success of any chronic disease management program.

Keywords: management, hypertension, diabetes mellitus type 2






 

Other articles by Dr Ramona Dejesus



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Ankle Brachial Pressure Index (ABPI): An update for practitioners
Cardiac risk stratification: Role of the coronary calcium score
Role of olmesartan in combination therapy in blood pressure control and vascular function
ABO and rhesus blood group distribution in Kurds
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University